Pharma & Healthcare
Global Pet Medicine Market Research Report 2024
- Jan 29, 24
- ID: 51034
- Pages: 96
- Figures: 205
- Views: 18
Well over half of the triplicate in the United States own a pet -- almost 80 million homes!Man 's best friend took a be the most iconic. But it' s been a dog, cat, horse, bird, fish, or lizard, pets need to be cared for, pet medical is required.
The global Pet Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 33%.
This report aims to provide a comprehensive presentation of the global market for Pet Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Medicine.
Report Scope
The Pet Medicine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Dechra Pharmaceuticals
Segment by Type
External Use
Internal Use
Segment by Application
Dogs
Cats
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Pet Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 33%.
This report aims to provide a comprehensive presentation of the global market for Pet Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Medicine.
Report Scope
The Pet Medicine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Dechra Pharmaceuticals
Segment by Type
External Use
Internal Use
Segment by Application
Dogs
Cats
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Pet Medicine Market Overview
1.1 Product Overview and Scope of Pet Medicine
1.2 Pet Medicine Segment by Type
1.2.1 Global Pet Medicine Market Value Comparison by Type (2024-2030)
1.2.2 External Use
1.2.3 Internal Use
1.3 Pet Medicine Segment by Application
1.3.1 Global Pet Medicine Market Value by Application: (2024-2030)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Global Pet Medicine Market Size Estimates and Forecasts
1.4.1 Global Pet Medicine Revenue 2019-2030
1.4.2 Global Pet Medicine Sales 2019-2030
1.4.3 Global Pet Medicine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pet Medicine Market Competition by Manufacturers
2.1 Global Pet Medicine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pet Medicine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pet Medicine Average Price by Manufacturers (2019-2024)
2.4 Global Pet Medicine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Medicine, Product Type & Application
2.7 Pet Medicine Market Competitive Situation and Trends
2.7.1 Pet Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Medicine Players Market Share by Revenue
2.7.3 Global Pet Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Medicine Retrospective Market Scenario by Region
3.1 Global Pet Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pet Medicine Global Pet Medicine Sales by Region: 2019-2030
3.2.1 Global Pet Medicine Sales by Region: 2019-2024
3.2.2 Global Pet Medicine Sales by Region: 2025-2030
3.3 Global Pet Medicine Global Pet Medicine Revenue by Region: 2019-2030
3.3.1 Global Pet Medicine Revenue by Region: 2019-2024
3.3.2 Global Pet Medicine Revenue by Region: 2025-2030
3.4 North America Pet Medicine Market Facts & Figures by Country
3.4.1 North America Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pet Medicine Sales by Country (2019-2030)
3.4.3 North America Pet Medicine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pet Medicine Market Facts & Figures by Country
3.5.1 Europe Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pet Medicine Sales by Country (2019-2030)
3.5.3 Europe Pet Medicine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pet Medicine Sales by Country (2019-2030)
3.6.3 Asia Pacific Pet Medicine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pet Medicine Market Facts & Figures by Country
3.7.1 Latin America Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pet Medicine Sales by Country (2019-2030)
3.7.3 Latin America Pet Medicine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pet Medicine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pet Medicine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pet Medicine Sales by Type (2019-2030)
4.1.1 Global Pet Medicine Sales by Type (2019-2024)
4.1.2 Global Pet Medicine Sales by Type (2025-2030)
4.1.3 Global Pet Medicine Sales Market Share by Type (2019-2030)
4.2 Global Pet Medicine Revenue by Type (2019-2030)
4.2.1 Global Pet Medicine Revenue by Type (2019-2024)
4.2.2 Global Pet Medicine Revenue by Type (2025-2030)
4.2.3 Global Pet Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Pet Medicine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pet Medicine Sales by Application (2019-2030)
5.1.1 Global Pet Medicine Sales by Application (2019-2024)
5.1.2 Global Pet Medicine Sales by Application (2025-2030)
5.1.3 Global Pet Medicine Sales Market Share by Application (2019-2030)
5.2 Global Pet Medicine Revenue by Application (2019-2030)
5.2.1 Global Pet Medicine Revenue by Application (2019-2024)
5.2.2 Global Pet Medicine Revenue by Application (2025-2030)
5.2.3 Global Pet Medicine Revenue Market Share by Application (2019-2030)
5.3 Global Pet Medicine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Pet Medicine Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Pet Medicine Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Pet Medicine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Pet Medicine Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer Pet Medicine Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Corporation Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Virbac Pet Medicine Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Ceva Sante Animale
6.6.1 Ceva Sante Animale Corporation Information
6.6.2 Ceva Sante Animale Description and Business Overview
6.6.3 Ceva Sante Animale Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Sante Animale Pet Medicine Product Portfolio
6.7.5 Ceva Sante Animale Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vetoquinol Pet Medicine Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Bimeda Animal Health
6.9.1 Bimeda Animal Health Corporation Information
6.9.2 Bimeda Animal Health Description and Business Overview
6.9.3 Bimeda Animal Health Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bimeda Animal Health Pet Medicine Product Portfolio
6.9.5 Bimeda Animal Health Recent Developments/Updates
6.10 Dechra Pharmaceuticals
6.10.1 Dechra Pharmaceuticals Corporation Information
6.10.2 Dechra Pharmaceuticals Description and Business Overview
6.10.3 Dechra Pharmaceuticals Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Dechra Pharmaceuticals Pet Medicine Product Portfolio
6.10.5 Dechra Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Medicine Industry Chain Analysis
7.2 Pet Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Medicine Production Mode & Process
7.4 Pet Medicine Sales and Marketing
7.4.1 Pet Medicine Sales Channels
7.4.2 Pet Medicine Distributors
7.5 Pet Medicine Customers
8 Pet Medicine Market Dynamics
8.1 Pet Medicine Industry Trends
8.2 Pet Medicine Market Drivers
8.3 Pet Medicine Market Challenges
8.4 Pet Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Pet Medicine
1.2 Pet Medicine Segment by Type
1.2.1 Global Pet Medicine Market Value Comparison by Type (2024-2030)
1.2.2 External Use
1.2.3 Internal Use
1.3 Pet Medicine Segment by Application
1.3.1 Global Pet Medicine Market Value by Application: (2024-2030)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Global Pet Medicine Market Size Estimates and Forecasts
1.4.1 Global Pet Medicine Revenue 2019-2030
1.4.2 Global Pet Medicine Sales 2019-2030
1.4.3 Global Pet Medicine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pet Medicine Market Competition by Manufacturers
2.1 Global Pet Medicine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pet Medicine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pet Medicine Average Price by Manufacturers (2019-2024)
2.4 Global Pet Medicine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Medicine, Product Type & Application
2.7 Pet Medicine Market Competitive Situation and Trends
2.7.1 Pet Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Medicine Players Market Share by Revenue
2.7.3 Global Pet Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Medicine Retrospective Market Scenario by Region
3.1 Global Pet Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pet Medicine Global Pet Medicine Sales by Region: 2019-2030
3.2.1 Global Pet Medicine Sales by Region: 2019-2024
3.2.2 Global Pet Medicine Sales by Region: 2025-2030
3.3 Global Pet Medicine Global Pet Medicine Revenue by Region: 2019-2030
3.3.1 Global Pet Medicine Revenue by Region: 2019-2024
3.3.2 Global Pet Medicine Revenue by Region: 2025-2030
3.4 North America Pet Medicine Market Facts & Figures by Country
3.4.1 North America Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pet Medicine Sales by Country (2019-2030)
3.4.3 North America Pet Medicine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pet Medicine Market Facts & Figures by Country
3.5.1 Europe Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pet Medicine Sales by Country (2019-2030)
3.5.3 Europe Pet Medicine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pet Medicine Sales by Country (2019-2030)
3.6.3 Asia Pacific Pet Medicine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pet Medicine Market Facts & Figures by Country
3.7.1 Latin America Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pet Medicine Sales by Country (2019-2030)
3.7.3 Latin America Pet Medicine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pet Medicine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pet Medicine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pet Medicine Sales by Type (2019-2030)
4.1.1 Global Pet Medicine Sales by Type (2019-2024)
4.1.2 Global Pet Medicine Sales by Type (2025-2030)
4.1.3 Global Pet Medicine Sales Market Share by Type (2019-2030)
4.2 Global Pet Medicine Revenue by Type (2019-2030)
4.2.1 Global Pet Medicine Revenue by Type (2019-2024)
4.2.2 Global Pet Medicine Revenue by Type (2025-2030)
4.2.3 Global Pet Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Pet Medicine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pet Medicine Sales by Application (2019-2030)
5.1.1 Global Pet Medicine Sales by Application (2019-2024)
5.1.2 Global Pet Medicine Sales by Application (2025-2030)
5.1.3 Global Pet Medicine Sales Market Share by Application (2019-2030)
5.2 Global Pet Medicine Revenue by Application (2019-2030)
5.2.1 Global Pet Medicine Revenue by Application (2019-2024)
5.2.2 Global Pet Medicine Revenue by Application (2025-2030)
5.2.3 Global Pet Medicine Revenue Market Share by Application (2019-2030)
5.3 Global Pet Medicine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Pet Medicine Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Pet Medicine Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Pet Medicine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Pet Medicine Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer Pet Medicine Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Corporation Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Virbac Pet Medicine Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Ceva Sante Animale
6.6.1 Ceva Sante Animale Corporation Information
6.6.2 Ceva Sante Animale Description and Business Overview
6.6.3 Ceva Sante Animale Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Sante Animale Pet Medicine Product Portfolio
6.7.5 Ceva Sante Animale Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vetoquinol Pet Medicine Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Bimeda Animal Health
6.9.1 Bimeda Animal Health Corporation Information
6.9.2 Bimeda Animal Health Description and Business Overview
6.9.3 Bimeda Animal Health Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bimeda Animal Health Pet Medicine Product Portfolio
6.9.5 Bimeda Animal Health Recent Developments/Updates
6.10 Dechra Pharmaceuticals
6.10.1 Dechra Pharmaceuticals Corporation Information
6.10.2 Dechra Pharmaceuticals Description and Business Overview
6.10.3 Dechra Pharmaceuticals Pet Medicine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Dechra Pharmaceuticals Pet Medicine Product Portfolio
6.10.5 Dechra Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Medicine Industry Chain Analysis
7.2 Pet Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Medicine Production Mode & Process
7.4 Pet Medicine Sales and Marketing
7.4.1 Pet Medicine Sales Channels
7.4.2 Pet Medicine Distributors
7.5 Pet Medicine Customers
8 Pet Medicine Market Dynamics
8.1 Pet Medicine Industry Trends
8.2 Pet Medicine Market Drivers
8.3 Pet Medicine Market Challenges
8.4 Pet Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pet Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pet Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pet Medicine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pet Medicine Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Pet Medicine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pet Medicine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pet Medicine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pet Medicine Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pet Medicine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pet Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pet Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Pet Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pet Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Medicine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pet Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pet Medicine Sales by Region (2019-2024) & (MT)
Table 18. Global Pet Medicine Sales Market Share by Region (2019-2024)
Table 19. Global Pet Medicine Sales by Region (2025-2030) & (MT)
Table 20. Global Pet Medicine Sales Market Share by Region (2025-2030)
Table 21. Global Pet Medicine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pet Medicine Revenue Market Share by Region (2019-2024)
Table 23. Global Pet Medicine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pet Medicine Revenue Market Share by Region (2025-2030)
Table 25. North America Pet Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pet Medicine Sales by Country (2019-2024) & (MT)
Table 27. North America Pet Medicine Sales by Country (2025-2030) & (MT)
Table 28. North America Pet Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pet Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pet Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pet Medicine Sales by Country (2019-2024) & (MT)
Table 32. Europe Pet Medicine Sales by Country (2025-2030) & (MT)
Table 33. Europe Pet Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pet Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pet Medicine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pet Medicine Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Pet Medicine Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Pet Medicine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pet Medicine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pet Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pet Medicine Sales by Country (2019-2024) & (MT)
Table 42. Latin America Pet Medicine Sales by Country (2025-2030) & (MT)
Table 43. Latin America Pet Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pet Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pet Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pet Medicine Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Pet Medicine Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Pet Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pet Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pet Medicine Sales (MT) by Type (2019-2024)
Table 51. Global Pet Medicine Sales (MT) by Type (2025-2030)
Table 52. Global Pet Medicine Sales Market Share by Type (2019-2024)
Table 53. Global Pet Medicine Sales Market Share by Type (2025-2030)
Table 54. Global Pet Medicine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pet Medicine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pet Medicine Revenue Market Share by Type (2019-2024)
Table 57. Global Pet Medicine Revenue Market Share by Type (2025-2030)
Table 58. Global Pet Medicine Price (USD/MT) by Type (2019-2024)
Table 59. Global Pet Medicine Price (USD/MT) by Type (2025-2030)
Table 60. Global Pet Medicine Sales (MT) by Application (2019-2024)
Table 61. Global Pet Medicine Sales (MT) by Application (2025-2030)
Table 62. Global Pet Medicine Sales Market Share by Application (2019-2024)
Table 63. Global Pet Medicine Sales Market Share by Application (2025-2030)
Table 64. Global Pet Medicine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pet Medicine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pet Medicine Revenue Market Share by Application (2019-2024)
Table 67. Global Pet Medicine Revenue Market Share by Application (2025-2030)
Table 68. Global Pet Medicine Price (USD/MT) by Application (2019-2024)
Table 69. Global Pet Medicine Price (USD/MT) by Application (2025-2030)
Table 70. Boehringer Ingelheim Corporation Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Boehringer Ingelheim Pet Medicine Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Zoetis Corporation Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Zoetis Pet Medicine Product
Table 79. Zoetis Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Merck Pet Medicine Product
Table 84. Merck Recent Developments/Updates
Table 85. Elanco Corporation Information
Table 86. Elanco Description and Business Overview
Table 87. Elanco Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Elanco Pet Medicine Product
Table 89. Elanco Recent Developments/Updates
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Bayer Pet Medicine Product
Table 94. Bayer Recent Developments/Updates
Table 95. Virbac Corporation Information
Table 96. Virbac Description and Business Overview
Table 97. Virbac Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Virbac Pet Medicine Product
Table 99. Virbac Recent Developments/Updates
Table 100. Ceva Sante Animale Corporation Information
Table 101. Ceva Sante Animale Description and Business Overview
Table 102. Ceva Sante Animale Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Ceva Sante Animale Pet Medicine Product
Table 104. Ceva Sante Animale Recent Developments/Updates
Table 105. Vetoquinol Corporation Information
Table 106. Vetoquinol Description and Business Overview
Table 107. Vetoquinol Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Vetoquinol Pet Medicine Product
Table 109. Vetoquinol Recent Developments/Updates
Table 110. Bimeda Animal Health Corporation Information
Table 111. Bimeda Animal Health Description and Business Overview
Table 112. Bimeda Animal Health Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Bimeda Animal Health Pet Medicine Product
Table 114. Bimeda Animal Health Recent Developments/Updates
Table 115. Dechra Pharmaceuticals Corporation Information
Table 116. Dechra Pharmaceuticals Description and Business Overview
Table 117. Dechra Pharmaceuticals Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Dechra Pharmaceuticals Pet Medicine Product
Table 119. Dechra Pharmaceuticals Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Pet Medicine Distributors List
Table 123. Pet Medicine Customers List
Table 124. Pet Medicine Market Trends
Table 125. Pet Medicine Market Drivers
Table 126. Pet Medicine Market Challenges
Table 127. Pet Medicine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pet Medicine
Figure 2. Global Pet Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pet Medicine Market Share by Type in 2023 & 2030
Figure 4. External Use Product Picture
Figure 5. Internal Use Product Picture
Figure 6. Global Pet Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pet Medicine Market Share by Application in 2023 & 2030
Figure 8. Dogs
Figure 9. Cats
Figure 10. Other
Figure 11. Global Pet Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Pet Medicine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Pet Medicine Sales (2019-2030) & (MT)
Figure 14. Global Pet Medicine Average Price (USD/MT) & (2019-2030)
Figure 15. Pet Medicine Report Years Considered
Figure 16. Pet Medicine Sales Share by Manufacturers in 2023
Figure 17. Global Pet Medicine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Pet Medicine Players: Market Share by Revenue in 2023
Figure 19. Pet Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Pet Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Pet Medicine Sales Market Share by Country (2019-2030)
Figure 22. North America Pet Medicine Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Pet Medicine Sales Market Share by Country (2019-2030)
Figure 26. Europe Pet Medicine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Pet Medicine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Pet Medicine Revenue Market Share by Region (2019-2030)
Figure 34. China Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Pet Medicine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Pet Medicine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Pet Medicine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Pet Medicine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Pet Medicine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Pet Medicine by Type (2019-2030)
Figure 56. Global Pet Medicine Price (USD/MT) by Type (2019-2030)
Figure 57. Global Sales Market Share of Pet Medicine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Pet Medicine by Application (2019-2030)
Figure 59. Global Pet Medicine Price (USD/MT) by Application (2019-2030)
Figure 60. Pet Medicine Value Chain
Figure 61. Pet Medicine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Pet Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pet Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pet Medicine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pet Medicine Sales (MT) of Key Manufacturers (2019-2024)
Table 5. Global Pet Medicine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pet Medicine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pet Medicine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pet Medicine Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pet Medicine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pet Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pet Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Pet Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pet Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Medicine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pet Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pet Medicine Sales by Region (2019-2024) & (MT)
Table 18. Global Pet Medicine Sales Market Share by Region (2019-2024)
Table 19. Global Pet Medicine Sales by Region (2025-2030) & (MT)
Table 20. Global Pet Medicine Sales Market Share by Region (2025-2030)
Table 21. Global Pet Medicine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pet Medicine Revenue Market Share by Region (2019-2024)
Table 23. Global Pet Medicine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pet Medicine Revenue Market Share by Region (2025-2030)
Table 25. North America Pet Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pet Medicine Sales by Country (2019-2024) & (MT)
Table 27. North America Pet Medicine Sales by Country (2025-2030) & (MT)
Table 28. North America Pet Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pet Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pet Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pet Medicine Sales by Country (2019-2024) & (MT)
Table 32. Europe Pet Medicine Sales by Country (2025-2030) & (MT)
Table 33. Europe Pet Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pet Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pet Medicine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pet Medicine Sales by Region (2019-2024) & (MT)
Table 37. Asia Pacific Pet Medicine Sales by Region (2025-2030) & (MT)
Table 38. Asia Pacific Pet Medicine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pet Medicine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pet Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pet Medicine Sales by Country (2019-2024) & (MT)
Table 42. Latin America Pet Medicine Sales by Country (2025-2030) & (MT)
Table 43. Latin America Pet Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pet Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pet Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pet Medicine Sales by Country (2019-2024) & (MT)
Table 47. Middle East & Africa Pet Medicine Sales by Country (2025-2030) & (MT)
Table 48. Middle East & Africa Pet Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pet Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pet Medicine Sales (MT) by Type (2019-2024)
Table 51. Global Pet Medicine Sales (MT) by Type (2025-2030)
Table 52. Global Pet Medicine Sales Market Share by Type (2019-2024)
Table 53. Global Pet Medicine Sales Market Share by Type (2025-2030)
Table 54. Global Pet Medicine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pet Medicine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pet Medicine Revenue Market Share by Type (2019-2024)
Table 57. Global Pet Medicine Revenue Market Share by Type (2025-2030)
Table 58. Global Pet Medicine Price (USD/MT) by Type (2019-2024)
Table 59. Global Pet Medicine Price (USD/MT) by Type (2025-2030)
Table 60. Global Pet Medicine Sales (MT) by Application (2019-2024)
Table 61. Global Pet Medicine Sales (MT) by Application (2025-2030)
Table 62. Global Pet Medicine Sales Market Share by Application (2019-2024)
Table 63. Global Pet Medicine Sales Market Share by Application (2025-2030)
Table 64. Global Pet Medicine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pet Medicine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pet Medicine Revenue Market Share by Application (2019-2024)
Table 67. Global Pet Medicine Revenue Market Share by Application (2025-2030)
Table 68. Global Pet Medicine Price (USD/MT) by Application (2019-2024)
Table 69. Global Pet Medicine Price (USD/MT) by Application (2025-2030)
Table 70. Boehringer Ingelheim Corporation Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Boehringer Ingelheim Pet Medicine Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Zoetis Corporation Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Zoetis Pet Medicine Product
Table 79. Zoetis Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Merck Pet Medicine Product
Table 84. Merck Recent Developments/Updates
Table 85. Elanco Corporation Information
Table 86. Elanco Description and Business Overview
Table 87. Elanco Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Elanco Pet Medicine Product
Table 89. Elanco Recent Developments/Updates
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Bayer Pet Medicine Product
Table 94. Bayer Recent Developments/Updates
Table 95. Virbac Corporation Information
Table 96. Virbac Description and Business Overview
Table 97. Virbac Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Virbac Pet Medicine Product
Table 99. Virbac Recent Developments/Updates
Table 100. Ceva Sante Animale Corporation Information
Table 101. Ceva Sante Animale Description and Business Overview
Table 102. Ceva Sante Animale Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Ceva Sante Animale Pet Medicine Product
Table 104. Ceva Sante Animale Recent Developments/Updates
Table 105. Vetoquinol Corporation Information
Table 106. Vetoquinol Description and Business Overview
Table 107. Vetoquinol Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Vetoquinol Pet Medicine Product
Table 109. Vetoquinol Recent Developments/Updates
Table 110. Bimeda Animal Health Corporation Information
Table 111. Bimeda Animal Health Description and Business Overview
Table 112. Bimeda Animal Health Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Bimeda Animal Health Pet Medicine Product
Table 114. Bimeda Animal Health Recent Developments/Updates
Table 115. Dechra Pharmaceuticals Corporation Information
Table 116. Dechra Pharmaceuticals Description and Business Overview
Table 117. Dechra Pharmaceuticals Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Dechra Pharmaceuticals Pet Medicine Product
Table 119. Dechra Pharmaceuticals Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Pet Medicine Distributors List
Table 123. Pet Medicine Customers List
Table 124. Pet Medicine Market Trends
Table 125. Pet Medicine Market Drivers
Table 126. Pet Medicine Market Challenges
Table 127. Pet Medicine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pet Medicine
Figure 2. Global Pet Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pet Medicine Market Share by Type in 2023 & 2030
Figure 4. External Use Product Picture
Figure 5. Internal Use Product Picture
Figure 6. Global Pet Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pet Medicine Market Share by Application in 2023 & 2030
Figure 8. Dogs
Figure 9. Cats
Figure 10. Other
Figure 11. Global Pet Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Pet Medicine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Pet Medicine Sales (2019-2030) & (MT)
Figure 14. Global Pet Medicine Average Price (USD/MT) & (2019-2030)
Figure 15. Pet Medicine Report Years Considered
Figure 16. Pet Medicine Sales Share by Manufacturers in 2023
Figure 17. Global Pet Medicine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Pet Medicine Players: Market Share by Revenue in 2023
Figure 19. Pet Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Pet Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Pet Medicine Sales Market Share by Country (2019-2030)
Figure 22. North America Pet Medicine Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Pet Medicine Sales Market Share by Country (2019-2030)
Figure 26. Europe Pet Medicine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Pet Medicine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Pet Medicine Revenue Market Share by Region (2019-2030)
Figure 34. China Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Pet Medicine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Pet Medicine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Pet Medicine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Pet Medicine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Pet Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Pet Medicine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Pet Medicine by Type (2019-2030)
Figure 56. Global Pet Medicine Price (USD/MT) by Type (2019-2030)
Figure 57. Global Sales Market Share of Pet Medicine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Pet Medicine by Application (2019-2030)
Figure 59. Global Pet Medicine Price (USD/MT) by Application (2019-2030)
Figure 60. Pet Medicine Value Chain
Figure 61. Pet Medicine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Food Grade FIBC Bulk Bags Market Research Report 2025
Jan 09, 25
Global Standard FIBC Market Research Report 2025
Jan 09, 25
Global Mammoplasty Retractors Market Research Report 2025
Jan 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232